To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects

Inclusion Criteria: * Subjects of both sexes (men or women) between 30 and 75 years of age, Caucasian. * Present body mass index between 20 and 32 Kg / m2. * Presenting fasting serum LDL-cholesterol levels equal to or greater than 110 mg / dL or total serum cholesterol equal to or greater than 180 mg / dL. * Volunteers capable of understanding the clinical study and willing to grant written informed consent and to comply with study procedures and requirements. Exclusion Criteria: * Thyroid dysfunction, infections, or with any type of chronic disease (eg, autoimmune, inflammatory). * Subjects who have suffered an ischemic-vascular event in the last months. * Subjects in medication and / or nutraceutical treatment for hypertension, diabetes or hyperlipidemia (ex: statins). * Subjects in treatment with drugs that due to their narrow therapeutic margin require monitoring of their plasma levels (digoxin, acenocoumarol, warfarin, etc ...). * Subjects in treatment that affects body weight or appetite. * History of allergic hypersensitivity or poor tolerance to any component of the products under study. * Subjects who are carrying out or intend to carry out any type of diet, low-calorie or not, during the study. * Subjects who have donated a minimum of 0.5L of blood in the last month Vegetarian subjects. * Subjects who have ingested omega 3 and / or 6 supplements in the last three months, (eg, fish oil, evening primrose oil, krill oil, or algae oil). * Subjects under treatment with niacin or fibrates. * Those subjects with alcohol abuse, or with excessive alcohol consumption (\> 3 glasses of wine or beer / day) were excluded. * Patients undergoing major surgery in the last 3 months. * Smoking subjects or not, but in any case who have changed their nicotinic habits during their participation in the study. * Participation in another clinical trial in the three months prior to the study. * Lack of will or inability to comply with clinical trial procedures. * Subjects whose condition did not make them eligible for the study according to the researcher's criteria.